BIKINI ZONE MEDICATED CREME- lidocaine cream 
CCA Industries, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Bikini Zone Medicated CREME

Drug Facts

Active Ingredient

LIDOCAINE 2.00%

Purpose

topical analgesic/anesthetic

Use

temporarily relieves pain and itching associated with minor skin irritation.

Warnings

For external use only.

Avoid contact with eyes

Do not use 

  • in large quantities, particularly over raw surfaces or blistered areas.
  • before any hair removal process that involves heat or lasers

Stop use and ask a doctor if

  • Condition worsens
  • Symptoms last for more than 7 days or clear up and occur again within a few days.
  • redness is present
  • irritation develops

Keep out of reach of children

In case of accidental ingestion, get medical help or contact a Poison Control Center right away.

Directions

adults and children 12 years and older

Other information

store at room temperature 15°-30°C (59°-86°F)

Inactive Ingredients

aloe barbadensis gel, benzyl alcohol, camphor, cetearyl alcohol, cyclohexasiloxane, cyclopentasiloxane, disodium edta, diazolidinyl urea, fragrance, glyceryl dilaurate, glyceryl stearate, hexylene glycol, lactic acid, menthol, methylparaben, octyldodecanol, peg-40 stearate, peg-100 stearate, polyquaternium-37, ppg-1 trideceth-6, propylene glycol dicaprylate/dicaprate, propylene glycol, propylparaben, salicylic acid, sd alcohol 23a, sodium hydroxide, water (aqua).

Questions or Comments?

 Call 1-800-595-6230 

Package Labeling:

Label

BIKINI ZONE MEDICATED CREME 
lidocaine cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:61543-1601
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE2 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
BENZYL ALCOHOL (UNII: LKG8494WBH)  
CAMPHOR (NATURAL) (UNII: N20HL7Q941)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CYCLOMETHICONE 6 (UNII: XHK3U310BA)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
LACTIC ACID (UNII: 33X04XA5AT)  
MENTHOL (UNII: L7T10EIP3A)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
POLYOXYL 100 STEARATE (UNII: YD01N1999R)  
PROPYLENE GLYCOL DICAPRYLATE (UNII: 581437HWX2)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
SALICYLIC ACID (UNII: O414PZ4LPZ)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:61543-1601-11 in 1 BOX03/15/2019
128 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333B06/03/2010
Labeler - CCA Industries, Inc. (106771041)

Revised: 12/2022
Document Id: eff14d9c-3c24-2f9d-e053-2995a90a3846
Set id: 091169e6-5021-431e-ab68-8c10e4f8f0c5
Version: 7
Effective Time: 20221216
 
CCA Industries, Inc.